Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices

被引：11
|
作者：
Dhruva, Sanket S. [1 ,2 ,3 ]
Mazure, Carolyn M. [4 ,5 ]
Ross, Joseph S. [1 ,6 ,7 ,8 ]
Redberg, Rita F. [9 ,10 ]
机构：
[1] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St,SHM I-456,POB 208088, New Haven, CT 06520 USA
[2] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA
[3] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA
[4] Yale Sch Med, Dept Psychiat, New Haven, CT USA
[5] Yale Sch Med, Womens Hlth Res Yale, New Haven, CT USA
[6] Yale Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT USA
[7] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA
[8] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA
[9] Univ Calif San Francisco, Dept Med, Div Cardiol, Sch Med, San Francisco, CA 94143 USA
[10] Univ Calif San Francisco, Sch Med, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA
来源：
JAMA INTERNAL MEDICINE | 2017年 / 177卷 / 09期
关键词：
D O I：
10.1001/jamainternmed.2017.3148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1390 / 1391
页数：3
相关论文
共 50 条
  • [1] Inclusion of demographic-specific information in studies supporting US Food & Drug Administration approval of high-risk medical devices (vol 177, pg 1390, 2017)
    Dhruva, S. S.
    Mazure, C. M.
    Ross, J. S.
    Redberg, R. F.
    [J]. JAMA INTERNAL MEDICINE, 2017, 177 (09) : 1400 - 1400
  • [2] Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
    Zheng, Sarah Y.
    Dhruva, Sanket S.
    Redberg, Rita F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 619 - 625
  • [3] Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices
    Ong, Caroline
    Ly, Vy K.
    Redberg, Rita F.
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (05) : 801 - 803
  • [4] Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
    Lee, Samuel J.
    Cho, Lauren
    Klang, Eyal
    Wall, James
    Rensi, Stefano
    Glicksberg, Benjamin S.
    [J]. JAMA NETWORK OPEN, 2021, 4 (06) : E2112562
  • [5] Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014
    Rathi, Vinay K.
    Wang, Bo
    Ross, Joseph S.
    Downing, Nicholas S.
    Kesselheim, Aaron S.
    Gray, Stacey T.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (02) : 285 - 288
  • [6] US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021
    Wunnava, Susmitha
    Miller, Timothy A.
    Narang, Claire
    Nathan, Meena
    Bourgeois, Florence T.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (06): : 580 - 582
  • [7] Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements
    Dubin, Jonathan R.
    Enriquez, Jonathan R.
    Cheng, An-Lin
    Campbell, Hunter
    Cil, Akin
    [J]. JAMA NETWORK OPEN, 2023, 6 (04) : E237699
  • [8] Approval of High-Risk Medical Devices in the US: Implications for Clinical Cardiology
    Rome, Benjamin N.
    Kramer, Daniel B.
    Kesselheim, Aaron S.
    [J]. CURRENT CARDIOLOGY REPORTS, 2014, 16 (06)
  • [9] Approval of High-Risk Medical Devices in the US: Implications for Clinical Cardiology
    Benjamin N. Rome
    Daniel B. Kramer
    Aaron S. Kesselheim
    [J]. Current Cardiology Reports, 2014, 16
  • [10] Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
    Rathi, Vinay K.
    Krumholz, Harlan M.
    Masoudi, Frederick A.
    Ross, Joseph S.
    [J]. JAMA NETWORK OPEN, 2020, 3 (08)
12345